Yasmine Rafidi

Yasmine Rafidi, CPA, has a diverse and extensive work experience in various roles related to finance and accounting. Starting in 2006, they worked as an Audit Senior at Caporicci & Larson, which later merged into Stonefield Josephson. Yasmine then moved on to Rubicon Group Holding as a Senior Accountant before becoming an Audit Senior at Stonefield Josephson (merged into Marcum). In 2011, they joined Grant Thornton LLP as an Audit Manager. Yasmine then transitioned to Gilead Sciences, where they held multiple managerial positions including Manager - Technical Accounting, Manager - SOX Compliance, and Manager - R&D FP&A. Yasmine continued to expand their expertise by working as an Associate Director - FP&A at Five Prime Therapeutics, Inc. and then as an Associate Director, Commercial FP&A at Adamas Pharmaceuticals, Inc. Currently, they are employed at Akero Therapeutics, holding various roles such as Director, FP&A, Controller, and VP, FP&A.

Yasmine Rafidi, CPA holds a B.S degree in Accounting & Finance from San Francisco State University.